Both NAFLD and obesity are characterized by increased circulating endotoxin and FFA levels [8] as well as enhanced TLR4 expression on liver cells (mainly Kupffer cells) [5, 9] and blood leukocytes (mainly monocytes) [10]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.